Global Glioblastoma Treatment Drugs Market Analysis 2015-2019 and Forecast 2020-2025
- 99S3755552
- 95 Pages
- February 2020
- Healthcare
The global Glioblastoma Treatment Drugs market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Glioblastoma Treatment Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
VEGF/VEGFR Inhibitor
Alkylating Agents
Miscellaneous Antineoplastic
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Arbor Pharms LLC.
Bristol-Myers Squibb Company
Emcure Pharmaceuticals Ltd.
F. Hoffmann-La Roche AG
Merck & Co.
Sandoz
Sigma-Tau Pharmaceuticals
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospital
Cancer Research Organization
Long Term Care Center
Diagnostic Centers
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
1 Industry Overview
1.1 Glioblastoma Treatment Drugs Industry
Figure Glioblastoma Treatment Drugs Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Glioblastoma Treatment Drugs
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Glioblastoma Treatment Drugs
1.2.2 Downstream
Table Application Segment of Glioblastoma Treatment Drugs
Table Global Glioblastoma Treatment Drugs Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Glioblastoma Treatment Drugs Market by Type
3.1 By Type
3.1.1 VEGF/VEGFR Inhibitor
Table Major Company List of VEGF/VEGFR Inhibitor
3.1.2 Alkylating Agents
Table Major Company List of Alkylating Agents
3.1.3 Miscellaneous Antineoplastic
Table Major Company List of Miscellaneous Antineoplastic
3.2 Market Size
Table Global Glioblastoma Treatment Drugs Market 2015-2019, by Type, in USD Million
Figure Global Glioblastoma Treatment Drugs Market Growth 2015-2019, by Type, in USD Million
Table Global Glioblastoma Treatment Drugs Market 2015-2019, by Type, in Volume
Figure Global Glioblastoma Treatment Drugs Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global Glioblastoma Treatment Drugs Market Forecast 2020-2025, by Type, in USD Million
Table Global Glioblastoma Treatment Drugs Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List
4.1 Arbor Pharms LLC. (Company Profile, Sales Data etc.)
4.1.1 Arbor Pharms LLC. Profile
Table Arbor Pharms LLC. Overview List
4.1.2 Arbor Pharms LLC. Products & Services
4.1.3 Arbor Pharms LLC. Business Operation Conditions
Table Business Operation of Arbor Pharms LLC. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Bristol-Myers Squibb Company (Company Profile, Sales Data etc.)
4.2.1 Bristol-Myers Squibb Company Profile
Table Bristol-Myers Squibb Company Overview List
4.2.2 Bristol-Myers Squibb Company Products & Services
4.2.3 Bristol-Myers Squibb Company Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Emcure Pharmaceuticals Ltd. (Company Profile, Sales Data etc.)
4.3.1 Emcure Pharmaceuticals Ltd. Profile
Table Emcure Pharmaceuticals Ltd. Overview List
4.3.2 Emcure Pharmaceuticals Ltd. Products & Services
4.3.3 Emcure Pharmaceuticals Ltd. Business Operation Conditions
Table Business Operation of Emcure Pharmaceuticals Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 F. Hoffmann-La Roche AG (Company Profile, Sales Data etc.)
4.4.1 F. Hoffmann-La Roche AG Profile
Table F. Hoffmann-La Roche AG Overview List
4.4.2 F. Hoffmann-La Roche AG Products & Services
4.4.3 F. Hoffmann-La Roche AG Business Operation Conditions
Table Business Operation of F. Hoffmann-La Roche AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Merck & Co. (Company Profile, Sales Data etc.)
4.5.1 Merck & Co. Profile
Table Merck & Co. Overview List
4.5.2 Merck & Co. Products & Services
4.5.3 Merck & Co. Business Operation Conditions
Table Business Operation of Merck & Co. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Sandoz (Company Profile, Sales Data etc.)
4.6.1 Sandoz Profile
Table Sandoz Overview List
4.6.2 Sandoz Products & Services
4.6.3 Sandoz Business Operation Conditions
Table Business Operation of Sandoz (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Sigma-Tau Pharmaceuticals (Company Profile, Sales Data etc.)
4.7.1 Sigma-Tau Pharmaceuticals Profile
Table Sigma-Tau Pharmaceuticals Overview List
4.7.2 Sigma-Tau Pharmaceuticals Products & Services
4.7.3 Sigma-Tau Pharmaceuticals Business Operation Conditions
Table Business Operation of Sigma-Tau Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Glioblastoma Treatment Drugs Sales Revenue 2015-2019, by Company, in USD Million
Table Global Glioblastoma Treatment Drugs Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global Glioblastoma Treatment Drugs Sales Revenue Share in 2019, by Company, in USD Million
Table Global Glioblastoma Treatment Drugs Sales Volume 2015-2019, by Company, in Volume
Table Global Glioblastoma Treatment Drugs Sales Volume Share 2015-2019, by Company, in Volume
Figure Global Glioblastoma Treatment Drugs Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America Glioblastoma Treatment Drugs Market Concentration, in 2019
Figure Europe Glioblastoma Treatment Drugs Market Market Concentration, in 2019
Figure Asia-Pacific Glioblastoma Treatment Drugs MMarket Concentration, in 2019
Figure South America Glioblastoma Treatment Drugs Market Concentration, in 2019
Figure Middle East & Africa Glioblastoma Treatment Drugs Market Concentration, in 2019
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital
Figure Glioblastoma Treatment Drugs Demand in Hospital, 2015-2019, in USD Million
Figure Glioblastoma Treatment Drugs Demand in Hospital, 2015-2019, in Volume
6.1.2 Demand in Cancer Research Organization
Figure Glioblastoma Treatment Drugs Demand in Cancer Research Organization, 2015-2019, in USD Million
Figure Glioblastoma Treatment Drugs Demand in Cancer Research Organization, 2015-2019, in Volume
6.1.3 Demand in Long Term Care Center
Figure Glioblastoma Treatment Drugs Demand in Long Term Care Center, 2015-2019, in USD Million
Figure Glioblastoma Treatment Drugs Demand in Long Term Care Center, 2015-2019, in Volume
6.1.4 Demand in Diagnostic Centers
Figure Glioblastoma Treatment Drugs Demand in Diagnostic Centers, 2015-2019, in USD Million
Figure Glioblastoma Treatment Drugs Demand in Diagnostic Centers, 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Glioblastoma Treatment Drugs Demand Forecast 2020-2025, by Application, in USD Million
Figure Glioblastoma Treatment Drugs Market Growth 2020-2025, by Application, in USD Million
Figure Glioblastoma Treatment Drugs Market Share in 2025, by Application, in USD Million
Table Glioblastoma Treatment Drugs Demand Forecast 2020-2025, by Application, in Volume
Table Glioblastoma Treatment Drugs Market Growth 2020-2025, by Application, in Volume
Table Glioblastoma Treatment Drugs Market Share in 2025, by Application, in Volume
7 Region Operation
7.1 Regional Production
Table Glioblastoma Treatment Drugs Production 2015-2019, by Region, in USD Million
Table Glioblastoma Treatment Drugs Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global Glioblastoma Treatment Drugs Market 2015-2019, by Region, in USD Million
Table Global Glioblastoma Treatment Drugs Market Share 2015-2019, by Region, in USD Million
Table Global Glioblastoma Treatment Drugs Market 2015-2019, by Region, in Volume
Table Global Glioblastoma Treatment Drugs Market Share 2015-2019, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Glioblastoma Treatment Drugs Market Size and Growth 2015-2019, in USD Million
Figure North America Glioblastoma Treatment Drugs Market Size and Growth 2015-2019, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Glioblastoma Treatment Drugs Market Size 2015-2019, by Country, in USD Million
Table North America Glioblastoma Treatment Drugs Market Size 2015-2019, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Glioblastoma Treatment Drugs Market Size and Growth 2015-2019, in USD Million
Figure Europe Glioblastoma Treatment Drugs Market Size and Growth 2015-2019, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Glioblastoma Treatment Drugs Market Size 2015-2019, by Country, in USD Million
Table Europe Glioblastoma Treatment Drugs Market Size 2015-2019, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Glioblastoma Treatment Drugs Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Glioblastoma Treatment Drugs Market Size and Growth 2015-2019, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Glioblastoma Treatment Drugs Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Glioblastoma Treatment Drugs Market Size 2015-2019, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Glioblastoma Treatment Drugs Market Size and Growth 2015-2019, in USD Million
Figure South America Glioblastoma Treatment Drugs Market Size and Growth 2015-2019, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Glioblastoma Treatment Drugs Market Size 2015-2019, by Country, in USD Million
Table South America Glioblastoma Treatment Drugs Market Size 2015-2019, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Glioblastoma Treatment Drugs Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Glioblastoma Treatment Drugs Market Size and Growth 2015-2019, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Glioblastoma Treatment Drugs Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Glioblastoma Treatment Drugs Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Glioblastoma Treatment Drugs Market Forecast 2020-2025, by Region, in USD Million
Table Glioblastoma Treatment Drugs Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
Table Upstream Segment of Glioblastoma Treatment Drugs
Table Application Segment of Glioblastoma Treatment Drugs
Table Global Glioblastoma Treatment Drugs Market 2015-2025, by Application, in USD Million
Table Major Company List of Alkylating Agents
Table Major Company List of Miscellaneous Antineoplastic
Table Global Glioblastoma Treatment Drugs Market 2015-2019, by Type, in USD Million
Table Global Glioblastoma Treatment Drugs Market 2015-2019, by Type, in Volume
Table Global Glioblastoma Treatment Drugs Market Forecast 2020-2025, by Type, in USD Million
Table Global Glioblastoma Treatment Drugs Market Forecast 2020-2025, by Type, in Volume
Table Arbor Pharms LLC. Overview List
Table Business Operation of Arbor Pharms LLC. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Company Overview List
Table Business Operation of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Emcure Pharmaceuticals Ltd. Overview List
Table Business Operation of Emcure Pharmaceuticals Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table F. Hoffmann-La Roche AG Overview List
Table Business Operation of F. Hoffmann-La Roche AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & Co. Overview List
Table Business Operation of Merck & Co. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sandoz Overview List
Table Business Operation of Sandoz (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sigma-Tau Pharmaceuticals Overview List
Table Business Operation of Sigma-Tau Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Glioblastoma Treatment Drugs Sales Revenue 2015-2019, by Company, in USD Million
Table Global Glioblastoma Treatment Drugs Sales Revenue Share 2015-2019, by Company, in USD Million
Table Global Glioblastoma Treatment Drugs Sales Volume 2015-2019, by Company, in Volume
Table Global Glioblastoma Treatment Drugs Sales Volume Share 2015-2019, by Company, in Volume
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Glioblastoma Treatment Drugs Demand Forecast 2020-2025, by Application, in USD Million
Table Glioblastoma Treatment Drugs Demand Forecast 2020-2025, by Application, in Volume
Table Glioblastoma Treatment Drugs Market Growth 2020-2025, by Application, in Volume
Table Glioblastoma Treatment Drugs Market Share in 2025, by Application, in Volume
Table Glioblastoma Treatment Drugs Production 2015-2019, by Region, in USD Million
Table Glioblastoma Treatment Drugs Production 2015-2019, by Region, in Volume
Table Global Glioblastoma Treatment Drugs Market 2015-2019, by Region, in USD Million
Table Global Glioblastoma Treatment Drugs Market Share 2015-2019, by Region, in USD Million
Table Global Glioblastoma Treatment Drugs Market 2015-2019, by Region, in Volume
Table Global Glioblastoma Treatment Drugs Market Share 2015-2019, by Region, in Volume
Table North America Glioblastoma Treatment Drugs Market Size 2015-2019, by Country, in USD Million
Table North America Glioblastoma Treatment Drugs Market Size 2015-2019, by Country, in Volume
Table Europe Glioblastoma Treatment Drugs Market Size 2015-2019, by Country, in USD Million
Table Europe Glioblastoma Treatment Drugs Market Size 2015-2019, by Country, in Volume
Table Asia-Pacific Glioblastoma Treatment Drugs Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Glioblastoma Treatment Drugs Market Size 2015-2019, by Country, in Volume
Table South America Glioblastoma Treatment Drugs Market Size 2015-2019, by Country, in USD Million
Table South America Glioblastoma Treatment Drugs Market Size 2015-2019, by Country, in Volume
Table Middle East & Africa Glioblastoma Treatment Drugs Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Glioblastoma Treatment Drugs Market Size 2015-2019, by Country, in Volume
Table Glioblastoma Treatment Drugs Market Forecast 2020-2025, by Region, in USD Million
Table Glioblastoma Treatment Drugs Market Forecast 2020-2025, by Region, in Volume
Table Price Factors List
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
